|
The Cochrane Collaboration
Cochrane Reviews |
| Explore | New + Updated | Other languages |
|
 |
Speech and language therapy for dysarthria due to non-progressive brain damageSellars C, Hughes T, Langhorne P
Bookmark this:
     more ...
SummarySpeech and language therapy for dysarthria due to non-progressive brain damageSpeech and language therapy treatments for people with dysarthria have not been tested in large clinical trials. Dysarthria is a speech problem which can be caused by a number of brain disorders including conditions such as stroke and head injury. Typical features of dysarthria include slurring of speech and quiet voice volume. Psychological distress is often experienced by people with dysarthria. Speech and language therapists employ a range of treatments to help people with dysarthria. There are no large clinical trials which have tested whether these treatments are effective.
This is a Cochrane review abstract and plain language summary, prepared and maintained by The Cochrane Collaboration, currently published in The Cochrane Database of Systematic Reviews 2010 Issue 1, Copyright © 2010 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd.. The full text of the review is available in The Cochrane Library (ISSN 1464-780X).
This version first published online:
April 23. 2001 AbstractBackgroundDysarthria is a common sequel of non-progressive brain damage (typically stroke and traumatic brain damage). Impairment-based therapy and a wide variety of compensatory management strategies are undertaken by speech and language therapists with this patient population. ObjectivesTo determine the efficacy of speech and language therapy interventions for adults with dysarthria following non-progressive brain damage. Search strategyWe searched the trials registers of the following Cochrane Groups: Stroke, Injuries, Movement Disorders and Infectious Diseases. We also searched the trials register of the Cochrane Rehabilitation and Related Therapies Field. The trials registers were last searched in September 2004. The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2004), MEDLINE (1966 to September 2004), EMBASE (1980 to September 2004), CINAHL (1983 to September 2004), PsycINFO (1974 to October 2004), and Linguistics and Language Behavior Abstracts (1983 to December 2004) were searched electronically. We handsearched the International Journal of Language and Communication Disorders (1966 to 2005, Issue 1) and selected conference proceedings, and scanned the reference lists of relevant articles. We approached colleagues and speech and language therapy training institutions to identify other possible published and unpublished studies. Selection criteriaUnconfounded randomised controlled trials (RCTs). Data collection and analysisOne author assessed trial quality. Two co-authors were available to examine any potential trials for possible inclusion in the review. Main resultsNo trials of the required standard were identified. Authors' conclusionsThere is no evidence of the quality required by this review to support or refute the effectiveness of speech and language therapy interventions for dysarthria following non-progressive brain damage. Despite the recent commencement of a RCT of optimised speech and language therapy for communication difficulties after stroke, there continues to be an urgent need for good quality research in this area. |